Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Theoretical Biology|April 24, 2007
A complex mathematical model of the human menstrual cycleIsabel Reinecke, Peter Deuflhard
Contraception|June 28, 2014
Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cyclesCarolyn L Westhoff, Isabel Reinecke, Keith Bangerter, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 9, 2014
Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptiveBirte Hofmann, Isabel Reinecke, Barbara Schuett, et al.
Journal of Clinical Pharmacology|September 13, 2018
An Integrated Population Pharmacokinetic Analysis to Characterize Levonorgestrel Pharmacokinetics After Different Administration RoutesIsabel Reinecke, Birte Hofmann, Emir Mesic, et al.
Journal of Clinical Pharmacology|December 8, 2016
Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis SymptomsIsabel Reinecke, Marcus-Hillert Schultze-Mosgau, Rüdiger Nave, et al.
Contraception|January 12, 2023
Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSsJeffrey T Jensen, Isabel Reinecke, Teun M Post, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 2, 2020
Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration routeBirte Maria Hofmann, Dan Apter, Johannes Bitzer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 28, 2017
Exposure-response relationship of regorafenib efficacy in patients with hepatocellular carcinomaAlexander Solms, Isabel Reinecke, Sabine Fiala-Buskies, et al.
American Journal of Obstetrics and Gynecology|November 24, 2022
The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trialLueder M Fels, Dustin Costescu, Carolina S Vieira, et al.
Journal of Thrombosis and Thrombolysis|April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolismIsabel Reinecke, Alexander Solms, Stefan Willmann, et al.
Pageof 2